Volume 3, Issue 4 (November 2016)                   IJML 2016, 3(4): 262-269 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hajipour H, Hamishehkar H, Raeisi S, Barghi S, Hasani A. Epigallocatechin-3-Gallate Induces Apoptosis through Up-regulation of Bax and Down-regulation of Bcl-2 in Prostate Cancer Cell Line. IJML. 2016; 3 (4) :262-269
URL: http://ijml.ssu.ac.ir/article-1-148-en.html
3Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. 4Department of Biochemistry and Clinical Laboratories, Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract:   (3093 Views)

Background and Aims: Epigallocatechin-3-gallate (EGCG) is a polyphenolic compound from green tea, which its anticancer effects on many types of cancers have been confirmed, but the molecular mechanism by which EGCG induces apoptosis remains unknown. The aim of the present study was to investigate anti-proliferative properties and apoptotic signaling pathway of EGCG on PC3 human prostate cancer cells.

Materials and Methods: Cytotoxic effect of EGCG on prostate cancer cell line (PC3) was evaluated by MTT assay. DAPI staining was carried out to determine the morphological appearance of cells. Finally, the expression of Bax and Bcl-2 (apoptosis-regulating genes) were evaluated by quantitative Real-time polymerase chain reaction (PCR).

Results: Cytotoxicity evaluations demonstrated that EGCG prevented prostate cancer cells growth in a time and dose depended manner, but the effect of treatment duration is more significant than effect of concentration. Cell growth inhibition was found to be accompanied by nucleus condensation or chromatin fragmentations which are signs of apoptosis, as assessed by DAPI staining. Quantitative Real-time PCR results demonstrated that EGCG causes up-regulation of Bax as a pro-apoptotic protein, and down-regulation of Bcl-2 as an anti-apoptotic protein, thus shifting the Bax/Bcl-2 ratio in favor of apoptosis.  

Conclusions: It is tempting to suggest that consumption of EGCG could be an effective strategy to inhibit prostate cancer. Our results demonstrated that increase in the ratio of Bax/Bcl-2, is the probable molecular mechanisms through which EGCG induces apoptosis in PC3 cells.

Full-Text [PDF 593 kb]   (878 Downloads)    
Type of Study: Research | Subject: Biochemistry
Received: 2017/01/29 | Accepted: 2017/01/29 | Published: 2017/01/29

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | International Journal of Medical Laboratory

Designed & Developed by : Yektaweb